معرفی
Dr Toby Pillinger is a Clinical Lecturer at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), Department of Psychosis Studies, and an emerging international authority on the physical-health consequences of psychotropic drugs. Holding dual membership of the Royal Colleges of Physicians and Psychiatrists, he has built a highly-cited portfolio of meta-analyses, cardiac-imaging studies and clinical guidelines that bridge psychiatry, endocrinology and cardiology.
Research in a nutshell
- Cardiometabolic adverse effects of antipsychotics and antidepressants
- Cardiac MRI phenotyping in schizophrenia and first-episode psychosis
- Network meta-analysis and systematic review methodology
- Immunopsychiatry and novel metabolic treatments (e.g., GLP-1 agonists)
- Personalised psychopharmacology and guideline development
Impact & recognition
His 2020 Lancet Psychiatry network meta-analysis comparing 18 antipsychotics has already informed UK NICE and WHO monitoring guidelines, while his 2019 Lancet Psychiatry Commission blueprint for protecting physical health in people with mental illness has been referenced by > 1,000 policy and clinical documents worldwide. A 752-page Wiley book, The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry, which he co-edited, is now a standard reference for British psychiatrists. Media uptake is broad (BBC, The Times, The Guardian), reflecting his success in translating complex meta-analytic data into actionable clinical recommendations.
Current grants & team science
Dr Pillinger currently leads two active cardiac-imaging grants (Brain & Behavior Research Foundation; Academy of Medical Sciences) and co-leads an industry-partnered programme evaluating GLP-1 receptor agonists as adjunctive treatments for psychosis. He supervises junior clinicians within the South London & Maudsley NHS Foundation Trust but does not yet hold formal PhD studentship appointments.
Awards & honours
- Royal College of Psychiatrists Early Career Academic Researcher of the Year (2024)
- British Association for Psychopharmacology Junior Clinical Psychopharmacology Award (2019)
- Royal Society of Medicine Mental Health Foundation Research Prize – Second Place (2019)
